Preladenant Market In Global
Preladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor. ... Read More
Valrubicin (CAS 56124-62-0) is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin.
This report contains market size and forecasts of Valrubicin in global, including the following market information:
Global Valrubicin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Valrubicin Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Valrubicin companies in 2021 (%)
The global Valrubicin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Valrubicin include Toronto Research Chemicals, Selleck Chemicals, Adooq Bioscience, CSNpharm, AbMole, Santa Cruz Biotechnology, BOC Sciences, Biosynth Carbosynth and BioVision, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Valrubicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Valrubicin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Valrubicin Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Valrubicin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Valrubicin Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Valrubicin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Valrubicin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Valrubicin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Valrubicin revenues share in global market, 2021 (%)
Key companies Valrubicin sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Valrubicin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Toronto Research Chemicals
Selleck Chemicals
Adooq Bioscience
CSNpharm
AbMole
Santa Cruz Biotechnology
BOC Sciences
Biosynth Carbosynth
BioVision
Cayman Chemical
Merck
TOKU-E
Taiclone
MuseChem
Pharmaffiliates
MedKoo Biosciences
Preladenant (CAS 377727-87-2) is a potent and selective antagonist at the adenosine A2A receptor. ... Read More
Monomethyl Fumarate (CAS 2756-87-8), the active metabolite of the psoriasis drug Fumaderm, is a p ... Read More
Acebilustat (CAS 943764-99-6), also known as ZK322, is a novel, oral, potent and selective leukot ... Read More
Dithranol (CAS 1143-38-0) is a hepsin activity inhibitor used for treatment of psoriasis. Dithran ... Read More